Brad Loncar
Entrepreneur, investor w/ a #biotech focus, avid reader, KC native, alumnus of @univmiami. đź‘»: bradloncar
Last synced from Twitter 2m ago
Genetically Modified Mosquitoes Mate With Local Species in Brazil
This is the opposite of what researchers intended.
WATCH LIVE: FTC Chairman Joe Simons speaks on antitrust law at Fordham conference – 09/13/2019
Federal Trade Commission Chairman Joseph Simons gives the keynote remarks at Fordham’s 46th annual conference on international antitrust law and policy. » Su...
New Moderna data shows mRNA can teach the body to make medicines
Moderna's new data shows that its custom messenger RNA can instruct the body's own cells to make medicines for two diseases.
Roche’s Tecentriq as a first-line monotherapy helped certain people with advanced non-small cell lung cancer live longer compared with chemotherapy
Brad Loncar
Tecentriq monotherapy hit on OS in the 1L NSCLC high PD-L1 subgroup.
5d
What We Know About Vaping-Related Lung Illness
Health officials are investigating six deaths and more than 450 potential cases of pulmonary illness in the U.S. related to vaping and e-cigarette products. Here are questions and answers.
How Immunotherapy Might Be Used to Treat Heart Failure
Modified immune cells may be trained not just to attack cancer, but any cells in the body that cause disease, a new study suggests.
For Advisors | Fiduciary Trust Company International
Fiduciary trust works in collaboration with clients' other advisors
Brad Loncar
The company I was working for on September 11th (Franklin Templeton/Fiduciary Trust) lost 97 people. fiduciarytrust.com/911-memorial #NeverForget
6d
WSJ News Exclusive | China’s Anbang to Sell U.S. Hotels for More Than $5.8 Billion
China’s Anbang has agreed to sell a luxury hotel portfolio for more than $5.8 billion even as a California individual had secretly created a series of fake deeds to transfer ownership for up to a half-dozen of the hotels.
AstraZeneca Sees 60% of China Sales From New Drugs in Five Years
AstraZeneca Sees 60% of China Sales From New Drugs in Five Years
Amgen Announces New Clinical Data Evaluating Novel Investigational KRAS(G12C) Inhibitor In Larger Patient Group At WCLC 2019
54% of 13 Evaluable Non-Small Cell Lung Cancer Patients Experienced a Partial Response at the Target Dose of 960 mg in the Ongoing Phase 1 Study 46% of Patients had Stable Disease for a Disease Control Rate of 100% at the Target Dose FDA Grants AMG...
1
Brad Loncar
Here's $AMGN press release on KRAS. 7/13 NSCLC patients on the target 960mg dose (54%) had a PR. The other 6 had SD.
9d
BeiGene to Hold Conference Call and Webcast on September 8, 2019 at 7:00 p.m. ET to Provide Corporate Update
CAMBRIDGE, Mass. and BEIJING, China , Sept. 08, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and...
WeWork Parent Weighs Slashing Its Valuation Roughly in Half
WeWork parent weighs slashing its valuation roughly in half to around $20 billion amid IPO skepticism, say people familiar with the matter
Subscribe to read
Brad Loncar
At $540M, this is the largest private capital investment in the biotech sector in China's mainland to date.
12d
Texas Doctor Stephen M. Hahn Is a Top Contender to Head FDA
The radiation oncologist at M.D. Anderson Cancer Center in Houston has emerged as a top candidate to be nominated by the Trump administration to become commissioner of the Food and Drug Administration.